Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.5.0.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2016
Dec. 31, 2015
Current Assets    
Cash and cash equivalents $ 1,484,099 $ 623,184
Restricted cash 35,021 325,832
Accounts receivable - project revenue and reimbursable project costs 69,696 139,797
Prepaid expenses and other current assets 189,511 168,029
Total Current Assets 1,778,327 1,256,842
Other Assets    
Patent costs 1,048,518 950,594
Total Assets 2,826,845 2,207,436
Current Liabilities    
Accounts payable and accrued liabilities 1,343,984 1,182,371
Note payable 68,036 0
Total Current Liabilities 1,412,020 1,182,371
Long-Term Liabilities    
Deferred lease abandonment liability 112,700 196,938
Derivative warrant liability 198,955 2,327,195
Total Liabilities 1,723,675 3,706,504
Commitments and contingencies
Stockholders' Equity (Deficiency)    
Preferred stock, $0.001 par value, 10,000,000 authorized shares, no shares issued and outstanding 0 0
Common stock, $0.001 par value, 100,000,000 authorized, 4,799,906 shares outstanding at June 30, 2016 and 3,725,819 shares outstanding at December 31, 2015 4,800 3,726
Additional paid-in capital 77,101,722 72,868,647
Accumulated Deficit (76,003,352) (74,371,441)
Total Stockholders' Equity (Deficiency) 1,103,170 (1,499,068)
Total Liabilities and Stockholders' Equity (Deficiency) $ 2,826,845 $ 2,207,436